144 results
8-K
BCDA
BioCardia Inc.
9 Feb 24
Unregistered Sales of Equity Securities
9:58am
to the satisfaction of customary closing conditions (the “Closing Date”).
The Warrants will be exercisable at an exercise price equal to $0.4423 per
8-K
EX-1.1
BCDA
BioCardia Inc.
6 Dec 23
Other Events
6:05am
of the representations and warranties of the Company herein, to the performance by the Company of its obligations hereunder and to the continuing satisfaction
424B5
BCDA
BioCardia Inc.
17 Nov 23
Prospectus supplement for primary offering
5:25pm
for more information.
Delivery of the shares of common stock offered hereby is expected to be made on or about November 20, 2023, subject to satisfaction … on or about November 20, 2023, subject to satisfaction of customary closing conditions.
Fees and Expenses
We have agreed to pay the placement agent
8-K
EX-99.1
tpi5y2y7gin
16 Nov 23
Securities Purchase Agreement
5:15pm
8-K
i58vlze8se6qcig56a
16 Nov 23
Securities Purchase Agreement
5:15pm
8-K
EX-5.1
pr66y3s
16 Nov 23
Securities Purchase Agreement
5:15pm
424B5
y5jm4bp
22 Jun 23
Prospectus supplement for primary offering
8:33am
8-K
EX-5.1
mcwtn8w0nu ip38
21 Jun 23
Securities Purchase Agreement
5:23pm
8-K
tmz 7hwnmhe3
21 Jun 23
Securities Purchase Agreement
5:23pm
8-K
EX-99.1
s61ts8qc8r8qu9njxfe5
21 Jun 23
Securities Purchase Agreement
5:23pm
8-K
ipl5i
15 Dec 22
Unregistered Sales of Equity Securities
7:00am